CA-NEXON-AMERICA
12.5.2020 00:41:09 CEST | Business Wire | Press release
Prepare for a thrilling ride as free-to-play mobile kart racer, KartRider Rush+ , launches on iOS and Android devices on May 12. Buckle up to experience a robust set of tracks, innovative and diverse game modes and countless kart customization options that redefine the world of kart racing games.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200511005971/en/
The latest iteration of the insanely popular KartRider franchise, KartRider Rush+ features over 50 race tracks and 20 karts at launch delivering unmatched kart and character customization options, ranging from decals, plates, skins and more.
KartRider Rush + is built for bursts of gameplay on the go or longer durations played with fellow racers offering something for everyone with several modes including:
- Story Mode: Story Mode allows players to fully immerse themselves in the game, learning about character backstories and showcasing various game modes.
- Speed Race Mode: This mode challenges racers to compete against each other and use their drifting skills to earn EXP that can unlock more challenging tracks.
- Arcade Mode: Whether playing solo or in teams, players can enjoy additional gameplay options within Arcade Mode, such as Item Race, Infini-Boost and Lucci Runner.
- Ranked Mode: From Bronze to Living Legend, players can rank up tiers and earn rewards such as K-Coins to purchase a variety of items in the Shop.
- Time Trial: This mode is all about beating the clock to become the fastest racer.
For players looking to achieve ultimate racing prowess, KartRider Rush+ introduces a Mentorship System, which allows racers to team up with mentors to improve their skills or sign up as mentors to guide other players. All players participating in this system will receive mentorship perks and rewards. The Club System also makes it easy for racers to join forces and work together to complete challenges, daily activities and earn rewards.
Additionally, all players will be able to claim the pre-registration milestone rewards until May 25th, 2020. Pre-registration rewards include Skelemech Kart, Slugger Dao Character, Angel Wing Headset, Star Driftmoji and Love Candy Balloon added as a bonus item after reaching 5 million pre-registrations ahead of launch.
To celebrate the launch, KartRider Rush+ has partnered with iconic peripheral manufacturer, HyperX. As part of the partnership, KartRider Rush+ will host giveaways of HyperX gaming peripherals including the HyperX Cloud MIX™ headset and the HyperX ChargePlay Clutch™ designed for longer, more comfortable gaming sessions.
KartRider Rush+ will be available globally in multiple languages including English, Korean, Thai, and Traditional Chinese. Visit https://kartrush.nexon.com for the latest updates and information.
Social Media: Twitch / Facebook / Twitter / Instagram / YouTube
Press Assets:
About KartRider Rush+ https://kartrush.nexon.com
Based on the popular online gaming phenomenon, KartRider , KartRider Rush+ is a free-to-play kart racing mobile game delivering all the racing action of its namesake on iOS and Android devices. With gorgeous 3D graphics, KartRider Rush+ offers players robust tracks, karts and game modes, just like its online counterpart accommodating every level, from racing novice to drifting champion.
About Nexon America Inc. http://www.nexon.net/corporate/about-nexon/
Founded in 2005, Nexon America Inc. delivers outstanding free-to-play online game expertise and live game support, taking the strengths of NEXON Co., Ltd. (“Nexon”) and applying them for uniquely western audiences. Nexon America has consistently sustained iconic franchises such as MapleStory and Mabinogi for more than a decade, which have gone on to break records and captivate players. With new projects on the horizon, Nexon America maintains the pioneering and innovative spirit of its parent company, employing its player-first approach, while designing the best possible gameplay experiences for the western market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005971/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer31.8.2026 12:00:00 CEST | Press release
Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEAZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with trastuzumab plus chemotherapy, meeting the remaining primary endpoint analysis of the study. IA2 also provided longer follow-up data for the TEVIMBRA plus ZIIHERA
GigaDevice Strengthens EMEA and Southeast Asia Market Reach Through Strategic Partnership with Rutronik31.8.2026 09:00:00 CEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced a new strategic franchise partnership with Rutronik Elektronische Bauelemente GmbH, one of Europe’s leading broadline distributors of electronic components. The agreement covers EMEA and Southeast Asia, including India, and provides customers with broader access to GigaDevice’s comprehensive portfolio of microcontrollers, sensors, and power management solutions. The partnership further strengthens GigaDevice’s distribution network and local market presence across key regions. With its strong presence across Europe and growing coverage in Southeast Asia, Rutronik provides GigaDevice with an established channel supported by extensive market reach, technical expertise, and customer relationships. The collaboration will help expand access to GigaDevice’s embedded solutions across a broad range of applications and industries, including indus
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom